Browse studies
Find your next paid study
3 recruiting studies matching your filters
Phase 2
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva
This Phase 2, Randomized, Double-Blind, Placebo-Controlled Study is intended to evaluate the Efficacy, Safety, and Tolerability and PK of INCB000928 administer…
Fibrodysplasia Ossificans Progressiva (FOP)
Estimated
~$10 – $8,750
Incyte CorporationNCT05090891
FOP Registry: A Global Registry for the Fibrodysplasia Ossificans Progressiva Community
The Fibrodysplasia Ossificans Progressiva (FOP) Registry is a global, non-interventional, voluntary database that captures demographic and disease data directl…
Fibrodysplasia Ossificans Progressiva (FOP)
Estimated
~$10 – $1,125
The International FOP AssociationNCT02745158
An Observational Study of IL1 Inhibition for Blocking ACVR1-Induced Flare Activity and Heterotopic Ossification in Fibrodysplasia Ossificans Progressiva (FOP)
This is an observational pre-post study to observe if the off label use of anti-IL1 therapies, such as anakinra or canakinumab, can block ACVR1-induced flare a…
Fibrodysplasia Ossificans Progressiva (FOP)
Estimated
~$10 – $675
University of California, San FranciscoNCT06724562